You have 9 free searches left this month | for more free features.

City

Arkhangel'sk (1)

Cheliabinsk (1)

Moscow (1)

Saint Petersburg (1)

Saint-Petersburg (1)

Condition

Hodgkin Lymphoma (1)

Unresectable or Metastatic Melanoma (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Biocad (1)

St. Petersburg State Pavlov Medical University (1)

Collaborator

N.N. Petrov National Medical Research Center of Oncology (1)

Intervention

prolgolimab (2)

combination with prolgolimab and bendamustine (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

prolgolimab

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hodgkin Lymphoma Trial in Saint Petersburg (Prolgolimab, Combination with prolgolimab and bendamustine)

Recruiting

Hodgkin Lymphoma

Prolgolimab
Combination with prolgolimab and bendamustine

Saint Petersburg, Russian Federation
+1 more

Mar 3, 2023

Unresectable or Metastatic Melanoma Trial in Russian Federation (Prolgolimab)

Active, not recruiting

Unresectable or Metastatic Melanoma

Prolgolimab

Arkhangel'sk, Russian Federation
+5 more

Mar 23, 2023